Arlene Chan - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Arlene Chan

This paper is made freely available by the publisher.

2023 Sara M. Tolaney

ORCID

, Arlene Chan

ORCID

, Katarina Petrakova, Suzette Delaloge

ORCID

, Mario Campone, Hiroji Iwata

ORCID

, Parvin F. Peddi

ORCID

, Peter A. Kaufman

ORCID

, Elisabeth De Kermadec, Qianying Liu, Patrick Cohen

ORCID

ORCID

, Lei Wang, Nils Ternès, Eric Boitier and 1 other authors

AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2022 Sherko Kuemmel

ORCID

, Mario Campone

ORCID

, Delphine Loirat, Rafael Lopez Lopez, J. Thaddeus Beck

ORCID

, Michelino De Laurentiis

ORCID

ORCID

ORCID

ORCID

, Guenther G. Steger

ORCID

, Esther Zamora Adelantado

ORCID

, Francois P. Duhoux

ORCID

, Richard Greil, Irene Kuter

ORCID

ORCID

and 13 other authors

A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer

Upload

This paper was not found in any repository, but could be made available legally by the author.

2021 On B. Chan, John C. Su

ORCID

, Anousha Yazdabadi, Arlene Chan

ORCID

Drug induced vitiligo‐like depigmentation from a CDK 4/6 inhibitor

Upload

Missing publications? Search for publications with a matching author name.